Group One Trading’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,180
| Closed | -$123K | – | 9011 |
|
|
2021
Q2 | $137K | Sell |
6,180
-15,837
| -72% | -$336K | ﹤0.01% | 5636 |
|
|
2021
Q1 | $578K | Sell |
22,017
-23,664
| -52% | -$563K | ﹤0.01% | 3852 |
|
|
2020
Q4 | $854K | Sell |
45,681
-15,827
| -26% | -$296K | ﹤0.01% | 2785 |
|
|
2020
Q3 | $1.04M | Buy |
61,508
+59,799
| +3,499% | +$1.16M | ﹤0.01% | 2155 |
|
|
2020
Q2 | $40K | Buy |
+1,709
| New | +$24.8K | ﹤0.01% | 4499 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | -$842 | – | 5929 |
|
|
2019
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 5018 |
|
|
2019
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 5034 |
|
|
2019
Q2 | $1K | Buy |
+100
| New | +$1.21K | ﹤0.01% | 4854 |
|
|
2017
Q3 | – | Sell |
-97
| Closed | -$1.39K | – | 5300 |
|
|
2017
Q2 | $2K | Sell |
97
-100
| -51% | -$1.44K | ﹤0.01% | 4598 |
|
|
2017
Q1 | $3K | Buy |
+197
| New | +$2.75K | ﹤0.01% | 4409 |
|
|
2016
Q4 | – | Sell |
-9,314
| Closed | -$164K | – | 4959 |
|
|
2016
Q3 | $180K | Buy |
+9,314
| New | +$182K | ﹤0.01% | 2542 |
|
|
2015
Q3 | – | Sell |
-1,372
| Closed | -$25.1K | – | 5312 |
|
|
2015
Q2 | $26K | Buy |
+1,372
| New | +$25.4K | ﹤0.01% | 3915 |
|
|
2014
Q4 | – | Sell |
-2,300
| Closed | -$39.5K | – | 5392 |
|
|
2014
Q3 | $41K | Buy |
+2,300
| New | +$45.2K | ﹤0.01% | 3674 |
|
Other funds holding VIVO
Group One Trading's VIVO Position: Q3 2021 in Review
Group One Trading sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 6,180 shares — an estimated $123K sold.
Group One Trading first reported a position in VIVO in Q3 2014 and held it in 13 quarters. The position peaked at $1.04M in Q3 2020. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.
- Group One Trading reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
- Group One Trading sold 6,180 Meridian Bioscience Inc shares in Q3 2021, an estimated $123K.
- Group One Trading first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 13 quarters.
- Group One Trading's Meridian Bioscience Inc position peaked at $1.04M in Q3 2020.
- 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.
Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.